Skip to main content

Table 1 Baseline characteristics between patients with and without ISMN

From: Long-term oral nitrate therapy is associated with adverse outcome in diabetic patients following elective percutaneous coronary intervention

Variable Without ISMN (n = 62) With ISMN (n = 46) P value
Baseline Demographics
Age, years 64.3 ± 10.1 65.0 ± 11.1 0.75
Male, n (%) 42(67.7) 31(86.1) 1.0
Body mass index, kg/m2 26.3 ± 3.9 25.0 ± 3.6 0.09
Hypertension, n (%) 15(24.2) 5(10.9) 0.09
Smoking, n (%) 29(46.8) 23(50.0) 0.70
Insulin therapy, n (%) 13(21.0) 7(15.2) 0.62
Creatinine, mmol/L 141.1 ± 137.4 128.8 ± 91.9 0.59
HbA1c, % 7.8 ± 2.6 7.8 ± 1.4 0.92
Total cholesterol, mmol/L 4.4 ± 1.0 4.5 ± 1.3 0.88
Triglyceride, mmol/L 1.9 ± 1.6 2.1 ± 4.0 0.76
HDL cholesterol, mmol/L 1.1 ± 0.2 1.2 ± 0.2 0.18
LDL cholesterol, mmol/L 2.6 ± 0.9 2.5 ± .7 0.76
Triple vessel disease, n (%) 3(4.8) 11(23.9) *0.01
Prior myocardial infarction, n (%) 15(24.2) 18(39.1) 0.14
Prior PCI, n (%) 17(27.4) 18(39.1) 0.21
Drug eluting stent, n (%) 43(69.4) 31(67.4) 0.84
Impaired LVEF < 50%, n(%) 13(21.0) 7(15.2) 0.62
Medications after PCI
Beta blocker, n (%) 50(80.6) 38(82.6) 1.0
Calcium channel blocker, n (%) 43(69.4) 29(63.0) 0.40
Statin, n (%) 54(87.1) 41(89.1) 1.0
ACEI/ARB, n (%) 53(85.5) 39(84.8) 0.77
Aldosterone blocker, n (%) 6(9.7) 1(2.2) 0.14
  1. Abbreviation: ACEI = Angiotensin converting enzyme inhibitor; ARB: Angiotensin receptor blocker; BMI = Body mass inex, HDL = High density lipoprotein; ISMN = Isosorbide-5-monitrate; LDL = Low density lipoprotein; LVEF = Left ventricular ejection fraction; PCI = Percutaneous coronary intervention;
  2. *: P < 0.05